钱多多股票论坛

trader1688.com
 FAQ FAQ RSS

支持168: Amazon Ebay Amazon(Canada)
Half


Post new topic Reply to topic  [ 544 Posts ]  Go to page Previous  1 ... 32, 33, 34, 35, 36, 37  Next
Author Message
 Post subject: Re: 盘前个股动态2016
PostPosted: 7/18/17 09:40 
Offline 模拟帐户

Joined: 12/18/09 00:28
Posts: 965
8:51 am Gapping down (SCANX) :

Gapping down
In reaction to disappointing earnings/guidance:

TTS -15.3%, ERIC -12.9%, HOG -9.4%, FND -5.5%, (offers prelim Q2 results and launches proposed secondary offering of 9 mln shares of common stock by stockholders including funds affiliated with Ares Management (ARES), Freeman Spogli Management and management/directors of the Company), SCSS -4.7%, ETH -3.9%, (Ethan Allen comments on business in advance of investor meeting; sees Q4 adj EPS of $0.41-0.42 vs $0.50 estimate and retail written orders +1.9%), PLG -2.9%, (also updates outlook and financing), CMA -2%, MDSO -1.2%, GS -1.2%, BRO -0.7%, .
M&A news:

FUEL -2.6% (to be acquired by Sizmek for $2.60/share in cash; pre-announces Q2 earnings)
Other news:

IMUC -38.5% (prices 5,000 shares of its Series B 8% Mandatorily Convertible Preferred Stock and related warrants to purchase up to 9,000 shares at par for gross proceeds of approx. $5 mln)
CBAY -9.7% (announces 10 mln share secondary offering)
VNOM -7.7% (Viper Energy Partners' subsidiary of Diamondback Energy commences offering of 11 mln common units representing limited partner interests)
REI -5.3% (intends to offer shares of its common stock in an underwritten public offering)
NLY -4.4% (to offer 60 mln shares of common stock in underwritten offering; updates Q2 guidance)
AUPH -4.2% (reliquishing Monday's gains related to anticipated appearance of CEO on MadMoney)
SHLD -1% (after closing up 12% on ESL Partners / Eddie Lampert stake affirmation and line of credit update)
Analyst comments:

CRUS -3.7% (downgraded to Underweight from Equal Weight at Barclays )
AMD -3.6% (downgraded to Underweight from Equal Weight at Barclays)
CCJ -1.5% (downgraded to Underperform from Neutral at Credit Suisse)
8:48 am Gapping up (SCANX) :

Gapping up
In reaction to strong earnings/guidance:

NFLX +9.5%, MOSY +6.2%, NVS +2.5%, ELS +1.7%, AMTD +1.6%, PLD +1.2%, LMT +1.2%, ANGO +1.1%, JNJ +0.6%, .
Other news:

MBRX +17.1% (signs a new technology license agreement with MD Anderson Cancer Center)
PBYI +8.7% (receives FDA approval for NERLYNX/neratinib in early stage HER2-overexpressed/amplified breast cancer)
PRAN +8.3% (announces research collaboration with Takeda Pharmaceuticals)
NVAX +7.9% (to host RSV F vaccine update conference call on July 24 at 4:30pm ET)
MDGS +7.7% (announces that the Chinese exclusive distribution agreement with Golden Grand has been expanded to account for the increased interest in MUSE systems in China)
RAD +7.4% (Rite Aid provides supplemental information on impact from Walgreens Boots Alliance Asset Purchase Agreement in response to a number of investor inquiries)
EGLT +4.9% (Highbridge Capital discloses 9.58% passive stake)
PRTK +2.6% (announces 'positive' top-line results from a pivotal Phase 3 clinical study comparing omadacycline to twice-daily oral linezolid in the treatment of acute bacterial skin and skin structure infections )
Analyst comments:

QDEL +2.9% (upgraded to Buy from Hold at Canaccord Genuity)
INFN +2.3% (initiated with a Buy at Craig Hallum)
XLNX +1.2% (upgraded to Equal Weight from Underweight at Barclays)
CMG +1.1% (upgraded to Buy from Hold at Maxim Group )


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 7/19/17 10:11 
Offline 模拟帐户

Joined: 12/18/09 00:28
Posts: 965
8:32 am Gapping down (SCANX) :

Gapping down
In reaction to disappointing earnings/guidance:

HDP -7.9%, (announces Pres/COO departure and mgmt changes; expects Q2 total GAAP revenue of $58-59 mln vs $57.2 mln consensus), CSX -4.5%, NTRS -4.5%, UAL -3.9%, IBM -2.8%, IBKR -2%, CCI -2%, NAVI -0.6%, .
Other news:

DRYS -29.3% (to effect a 1-for-7 reverse stock split of the Company's issued common shares)
CYCC -26.8% (filed Form EFFECT (Notice of Effectiveness) for an S-1, which was described in an S-1MEF filing)
SPEX -19.1% (after filing another amended S-1 with offering of approx 1.18 mln shares of common stock)
OHGI -11.4% (discloses entry into securities purchase agreement with two investors)
INO -9.2% (to offer $75.0 mln of shares of its common stock in an underwritten public offering)
GLPG -6.1% (ticking lower; attributed to VRTX news)
MMYT -4.6% (files for 15,357,028 ordinary share offering by shareholders)
NSC -1% (plans to consolidate its Central Division headquarters operations in Knoxville into three surrounding divisions; move will affect a total of about 50 employees)
UNP -0.9% (CSX sympathy)
Analyst comments:

FBHS -1.1% (downgraded to Market Perform from Outperform at Wells Fargo)
PYPL -1% (downgraded to Hold from Buy at SunTrust)
AMC -0.7% (downgraded to Equal Weight from Overweight at Barclays)
CMG -0.7% (downgraded to Market Perform from Outperform at BMO Capital Markets; downgraded to Market Perform from Outperform at Wells Fargo)
8:24 am Gapping up (SCANX) :

Gapping up
In reaction to strong earnings/guidance:

EXPO +12%, DBD +5.4%, ADTN +4.9%, ASML +2.9%, MS +2.3%, UCFC +1.6%, WTFC +1.5%, TESS +1.1%, TXT +0.8%, UFPI +0.6%, AMX +0.5%
M&A news:

SNI +14.6% (WSJ reporting that Discovery Communications and Scripps are exploring M&A deal)
DISCA +7.6% (WSJ reporting that Discovery Communications and Scripps are exploring M&A deal)
Other news:

AEZS +47.1% (Aeterna Zentaris confirms the FDA granted NDA for Macrilen for the evaluation of growth hormone deficiency in adults December 30, 2017 PDUFA date )
PED +29.2% (provided transaction update; asset due diligence completed, successfully definitive documents now being drafted and anticipates closing by August 31, 2017
VRTX +27.3% (announces 'positive' Phase 1 & Phase 2 data from three different triple combination regimens in people with cystic fibrosis who have one F508del mutation and one minimal function mutation)
OPGN +12.6% (CFO and CEO disclose purchases likely made under July 13 offering priced at $0.40/share)
XGTI +12.5% (receives an order valued at approx. $1.5 mln for microwave communications equipment from a 'leading' medical device manufacturer)
MDGS +5.8% (announces a distribution agreement in Spain with Izasa Hospital who will be required to purchase a minimum of EUR 1.4 mln of MUSE equipment over the course of the agreement)
JONE +3.6% (reports Q2 production exceeding high end of guidance; schedules call to discuss mid-year updates tomorrow)
EXTR +2.8% (Extreme Networks provides update on acquisition of Brocade data center networking business from Broadcom (AVGO); says delay will provide additional time to integrate Avaya operations)
WKHS +2.2% (after seeing notable move higher Tuesday afternoon)
ANF +1.1% ( SLS Management sends letter to the Board outlining actionable steps for it to undertake to maximize value for the shareholders)
MU +0.7% (in sympathy with ASML)
AMD +0.7% (in sympathy with ASML)
Analyst comments:

JASO +3.4% (upgraded to Hold at Axiom Capital)
FSLR +2.4% (upgraded to Buy at Axiom Capital)
TRIP +1.9% (upgraded to Market Perform from Underperform at Cowen)
BA +0.6% (upgraded to Neutral from Underperform at BofA/Merrill)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 7/20/17 11:05 
Offline 模拟帐户

Joined: 12/18/09 00:28
Posts: 965
8:08 am Gapping down (SCANX) :

Gapping down
In reaction to disappointing earnings/guidance:

PTC -10.9%, CHRW -6.8%, ABB -3.7%, BG -3.4%, (expects Q2 adj earnings to be modestly profitable but below low end of the range of analyst estimates primarily driven by challenging ag market conditions; details $250 mln Competitiveness Program ), AA -3%, CHKP -3%, SHW -2.7%, STLD -2.2%, PM -2.1%, QCOM -2%, AXP -1.7%, SAP -1.6%, TRV -1.2%, SON -0.8%
Other news:

CFRX -13.8% (commences public offering of its common stock and warrants to purchase additional shares of its common stock; all of the securities in the offering are to be sold by ContraFect)
GOOD -6.3% (to sell shares of its common stock in an underwritten public offering)
WES -5.9% (being attributed to block trade pricing)
INO -4.9% (prices offering of 12.5 mln shares of common stock at $6.00 per share)
RGLS -2.1% (prices 44 mln shares of common stock at $0.91 per share)
FND -0.5% (prices 10,718,550 common stock offering by selling stockholders)
Analyst comments:

FMSA -7% (downgraded to Sell from Neutral at Goldman)
RNG -1.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
PFE -0.6% (downgraded to Neutral from Outperform at Credit Suisse)
8:04 am Gapping up (SCANX) :

Gapping up
In reaction to strong earnings/guidance:

HPJ +19.5%, SRPT +18%, DWCH +6.3%, PLXS +6.1%, KMI +4%, HAWK +3.9%, URI +3.6%, TMUS +2.9%, VMI +2.5%, AEHR +2.4%, ABT +1.2%, DOV +1%, EWBC +0.9%, KEY +0.7%, UN +0.7%, FPI +0.6%
M&A news:

AVA +18.1% (Avista to be acquired by Hydro One for $53/share), CAMT +5.2% (to sell its PCB business for $35 million)
Other news:

BVXV +10.6% (reports results from the Phase 2b clinical trial of M-001)
ALIM +6.6% (announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (:MHRA) has given final approval to reduce the size of its ILUVIEN Registry Safety Study)
AEZS +4.7% (continued strength)
MGM +2.8% (to join S&P 500)
ERIC +1.8% (slightly rebounding following recent weakness post earnings)
RMD +1% (to join S&P 500)
STM +1% (says recent media speculation that it may resume taking MCU orders after year-end is false)
TEVA +0.9% (receives NICE recommendation for CINQAERO)
Analyst comments:

NKE +2.3% (upgraded Overweight from Equal-Weight at Morgan Stanley; tgt $68)
BGS +2.1% (upgraded to Buy from Neutral at Citigroup)
RCL +0.6% (upgraded to Overweight from Neutral at JP Morgan)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 7/26/17 22:20 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
https://www.google.com/amp/s/www.yahoo. ... 29772.html 8:37 am Gapping down (SCANX) : Gapping down In reaction to disappointing earnings/guidance: FH -19.1%, USNA -14%, AKAM -6.7%, UHS -6.7%, WYNN -4.4%, CHGG -4.2%, SIX -4.1%, USG -3.8%, CSL -3.6%, AMGN -2.9%, HA -2.9%, DHI -2.7%, ANGI -2.7%, LN -2.6%, SFLY -2.3%, BKU -2%, F -2%, ESRX -1.9%, RHI -1.8%, JNPR -1.5%, HT -1.5%, IR -1.4%, AOS -0.9%, . Other news: OEC -6.8% (offers prelim Q2 results, prices secondary offering by selling shareholders of 10 mln shares of common stock at $21.85) MC -4.3% (prices 6 mln shares of common stock at $42.00 per share) APRN -3.3% (details several changes to executive leadership team; Co-Founder and Chief Operating Officer Matthew Wadiak stepping down from role) PLX -2.6% (enters exchange agreement of $9 mln of its 4.50% Senior Convertible Notes due 2018 for $8.55 million aggregate principal amount of newly issued 4.50% Senior Convertible Notes due 2022) MLCO -2% (WYNN sympathy) LVS -1.4% (WYNN sympathy) Analyst comments: DISH -1.7% (downgraded to Sell at Citigroup) LAMR -1.4% (downgraded to Market Perform from Outperform at Wells Fargo) PWR -1.2% (downgraded to Neutral at Robert Baird) JBLU -1.1% (downgraded to Neutral from Buy at Buckingham Research) ZTS -0.8% (downgraded last night to Hold from Buy at Deutsche Bank) 8:34 am Gapping up (SCANX) : Gapping up In reaction to strong earnings/guidance: OPHT +11.4%, AMD +9.4%, X +7.6%, SFS +7.4%, EXAS +7.2%, RCKY +3.8%, TRN +3.6%, RES +3.6%, SLAB +3.5%, SN +3.5%, ZION +3%, BGCP +2.8%, T +2.7%, CMG +2.6%, WES +2.1%, STM +1.9%, BA +1.7%, LUV +1.7%, CMRE +1.6%, BAX +1.5%, APH +1.5%, TSS +1.4%, NYCB +1.4%, IVTY +1.3%, LEA +1% M&A news: IRBT +20.6%, (to acquire privately-held Robopolis SAS for $141 mln ) GUID +2.8% (to be acquired by OpenText (OTEX) for $7.10 per share) SNI +1.3% (Viacom (VIAB) said to be willing to make an all-cash offer for Scripps, according to Reuters) SHPG +1% (renewed M&A speculation) Other news: TTPH +28.6% (Tetraphase Pharmaceuticals announces top-line results from IGNITE4, the Company's phase 3 clinical trial evaluating the efficacy and safety of twice-daily intravenous (:IV) eravacycline compared to meropenem for the treatment of patients with complicated intra-abdominal infections) ARGS +25% (announces publication of immunogenicity data from a study of AGS-004 dendritic cell therapy in patients treated during acute HIV infection in the Journal of AIDS Research and Human Retroviruses) ETRM +19.3% (enters into Collaboration Agreement with Galvani Bioelectronics Limited) MDGS +5.1% (distribution agreement in Switzerland and Liechtenstein with ADMEDICS) BLRX +2.2% (announces that BVF Partners will make an additional, direct investment of $9.6 million in BioLineRx, increasing its economic interest in the Company to 24.9%) EVGN +2.2% (enter into multiyear collaboration with DuPont) NVDA +1.4% (in sympathy with AMD) Analyst comments: OCUL +3.7% (initiated with a Buy at H.C. Wainwright) EA +2% (upgraded to Buy from Neutral at BofA/Merrill) DSW +1.9% (upgraded to Outperform from Neutral at Wedbush) 4:32 pm Esperion Therapeutics initiates Phase 2 clinical study (1002-039) to assess the efficacy and safety of bempedoic acid when added-on to an injectable proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) therapy (ESPR) : The eight-week, Phase 2, randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of once-daily, oral bempedoic acid 180 mg and once-monthly injection of Repatha (evolocumab) 420 mg versus placebo. The study is expected to enroll approximately 50 patients with hypercholesterolemia at approximately 20 sites across the U.S. The primary objective of the study is to assess the incremental LDL-C lowering efficacy of bempedoic acid versus placebo in patients receiving PCSK9i therapy. Secondary objectives include assessing the safety and tolerability of bempedoic acid versus placebo in patients on PCSK9i therapy and effects on other risk markers, including non-high-density lipoprotein cholesterol (non-HDL-C), total cholesterol, apolipoprotein B (apoB) and high sensitivity C-reactive protein (.... Dynavax Technologies Corporation (NASDAQ:DVAX) shares endured a volatile session, slipping over 20% in early trading before closing up 5% to $10.40 as investors digested key points noted in the FDA briefing documents released Wednesday for Friday’s Advisory Committee Meeting. The executive summary noted robust efficacy but with a lack of clarity in regard to safety: In summary, Heplisav was shown to have a robust immune response in healthy adults 18- 70 years of age in Studies DV2-HBV-10 and-16. Heplisav met pre-specified noninferiority criteria to an active comparator vaccine, Engerix-B, in these two phase 3 clinical trials. Regarding safety, there appear to be imbalances in deaths and SAEs of MI in DV2-HBV-23, and imbalances in AESIs in DV2-HBV-16 and -23 (the studies that prospectively evaluated these events). Numbers and rates of events are low, and the lack of prospectively defined monitoring and evaluation of cardiac events limits the causal interpretation of these observations. https://www.fda.gov/downloads/AdvisoryC ... 568492.pdf . egrx, crl from FDA, ⬇ 24%, additional trials required . IntelliPharmaCeutics Intl Inc (NASDAQ:IPCI) - An FDA Advisory Committee voted 22-1 against recommending approval, Pdufa date 9/25/17. 7/27/2017 dvax is⬇11%。。。 5:52 pm Amgen: FDA grants priority review for Repatha (evolocumab) sBLA to include data on reducing risk of cardiovascular events; PDUFA action date set for Dec 2 2017 (AMGN) : If approved by the FDA, the U.S. Prescribing Information for Repatha will be updated to include risk reduction of major cardiovascular events based on data from the large cardiovascular outcomes study (:FOURIER). The FDA has set a Prescription Drug User Fee Act (:PDUFA) action date of Dec. 2, 2017. A second application seeking to expand the lipid-lowering indication to include additional patient populations studied was also accepted by the FDA. 4:15 pm Agile Therapeutics: FDA has accepted for review its NDA resubmission for Twirla (AG200-15), an investigational low-dose combined hormonal contraceptive patch; PDUFA set for December 26, 2017 (AGRX) :


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/11/17 09:20 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
08:40  SCANX Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • UNXL -27.3%, (also discloses entry into equity purchase agreement with L2 Capital relating to an offering of an aggregate of up to 14,146,649 shares ), JCP -22.5%, LXFT -17.8%, SNAP -11.3%, NVDA -8.4%, BBOX -7.4%, UPLD -6.3%, KINS -5.4%, SPHS -5.2%, BIOC -4.8%, CXRX -4.6%, CBAY -3.9%, TU -1.6%, MGA -1%

Select China related names showing weakness after Shanghai closed down 1.6% overnight:

  • WB -2.9%, NTES -2.6%, MOMO -2.6%, SINA -2%, CTRP -2%, BIDU -1.6%, JD -1.5%

Select NVDA peers/related names trading lower:

  • AMD -2.3%, MU -1.6%, SOXX -1.2%, XLNX -1%

Other news:

  • ETRM -35.3% ( commences public offering to consist of units comprised of one share of series B convertible preferred stock and one warrant to purchase shares of common stock)
  • IONS -6.3% (announces 'a reprioritization of its pipeline and strategic review of its Rare Diseases business', after GSK (GSK) declined its options on inotersen and IONIS-FB-LRx)
  • NCLH -4% (launches secondary public offering of 15 million of its ordinary shares by certain funds affiliated with Apollo Global, Star NCLC Holdings Ltd. and certain funds affiliated with TPG Global)
  • TXMD -3.5% (announces regulatory update regarding the NDA for TX-004HR)
  • CBI -2.7% (continued weakness)
  • SQ -1.6% (continued weakness - closed down nearly 4% today)
  • LYV -1.5% (following late move lower on reports that Amazon may sell event tickets)
  • KSS -1.1% (in sympathy with JCP)

Analyst comments:

  • LTC -1.7% (downgraded to Underperform at BMO Capital Markets)
  • KR -1% (initiated with a Underweight at Stephens)
  • NNA -0.7% (downgraded to Neutral at Citigroup)
  • FRTA -0.6% (downgraded to Equal Weight from Overweight at Barclays)
  • SHPG -0.5% (downgraded to Equal Weight from Overweight at Barclays )
  • GS -0.5% (downgraded to Hold from Buy at HSBC Securities)


08:36  SCANX Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • VIVE +27.5%, AEZS +15%, CDNA +14.9%, CHMA +14.3%, (also has reached agreement with the FDA on the design of a new Phase 3 clinical trial for its octreotide capsules product candidate, Mycapssa), HEAR +11.9%, ANW +10.8%, TTD +7.5%, AMRS +5.9%, CWH +5.7%, EPAY +4.9%, CAPR +4.7%, NDLS +3.8%, CATB +2.5%, CYTX +2.4%, WPM +1.6%, CRSP +1.1%, ZSAN +1.1%

Other news:

  • DRYS +4.9% (announces agreement to conduct a private placement and subsequent rights offering at $2.75/share; terminates common stock purchase agreement with Kalani Investments)
    • TOPS +41.8% (following stock offering news from peer DryShips (DRYS))
  • CUDA +3.9% (to Join S&P SmallCap 600)
  • XXII +3.2% (ongoing volatility)
  • STX +3% (ValueAct Capital discloses 7.2% active stake after increasing position to 21 mln shares (showed 9.54 mln share position at end of Q1))
  • KURA +2.3% (prices offering of 7.7 mln shares of common stock at $6.50 per share)
  • EFII +2% ( files to delay its 10-Q; updates Q2 expectations excluding any adjustments from ongoing assessment/audit review)
  • ETSY +0.9% (Pres/CEO disclosed purchase of 64000 shares worth approx $1 mln)

Analyst comments:

  • PM +0.9% (upgraded to Hold at SBG Securities)
  • SBBP +0.8% (initiated with an Outperform at Oppenheimer; $12 tgt)


WRAPX This week's biggest % gainers/losers The following are this week's top 20 percentage gainers and top 20 percentage losers, categorized by sectors (over $300 mln market cap and 100K average daily volume). This week's top 20 % gainers Healthcare: MYOK (36.7 +113.99%), EDIT (21.95 +28.66%), NTRA (10.62 +28.11%), NXTM (29.22 +26.27%), ACHN (4.7 +19.16%), FGEN (41.65 +19%), PRGO (78.49 +16.4%), EGRX (55.64 +16.4%), IPXL (18.3 +15.09%), CYH (7.45 +14.26%) Industrials: STS (20.95 +38.47%), HTZ (18.65 +30.24%) Consumer Discretionary: KORS (44.69 +21.44%), CROX (9.21 +15.99%), ERI (23.4 +15.27%) Information Technology: ATHM (61.52 +28.65%), EFII (31.81 +22.11%), SSNI (12.95 +15.94%), BITA (36.91 +14.52%) Consumer Staples: CHEF (17.6 +20.96%) This week's top 20 % losers Healthcare: SGRY (11.03 -43.75%), DEPO (6.32 -33.26%), CCXI (7.2 -30.7%), BLCM (7.96 -25.88%), EVH (18.4 -23.65%) Materials: FRTA (4.64 -46.48%) Industrials: BW (2.91 -70.99%), CBI (11.8 -30.47%), CECE (7.45 -23.27%) Consumer Discretionary: FOSL (8.2 -29.55%), ODP (4.27 -28.11%), JCP (3.93 -27.76%), FTD (13.85 -27.03%) Information Technology: LXFT (45.7 -25.57%), CALX (5.04 -24.78%) Financials: MHLD (7 -36.94%) Energy: OSG (2.2 -27.15%), TTI (1.99 -23.17%) Consumer Staples: BETR (7.63 -21.82%)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/14/17 10:17 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping up
In reaction to strong earnings/guidance:

MBRX +1.1%, EBIO +0.7%
M&A news:

CSFL +0.8% (will acquire HCBF Holding for $416.7 mln in CFSL stock and Sunshine Bancorp for $176.7 mln in CFSL stock)
VFC +0.7% (to acquire Williamson-Dickie shareholders for approximately $820 million in cash, revises FY 17 outlook)
Select fan favorites names showing strength:

EA +0.9%, AAPL +0.9%, FB +0.8%, AMZN +0.7%
Select China releated stocks trading higher after Shanghai gained nearly 1% overnight:

WB +1.5%, YNDX +1.5%, MOMO +1%, BIDU +1%
Select semiconductor names showing strength:

TSEM +5.6%, AMD +2.4%, MU +2%, NVDA +1.2%, NTES +1.1%
Other news:

CVM +60.2% (FDA removes clinical hold on its Phase 3 cancer study w/ Multikine)
CHMA +5.4% (continued strength)
LLEX +5.3% (reports 2Q17 operating results)
FCAU +4.9% (said to have rejected a takeover approach from a Chinese automaker, according to Automotive News)
ON +2.9% (Coatue Management disclosed new position)
GLPG +2.5% (continued strength)
MTW +2.1% (clarifies Defense Logistics Agency contract announcement - is active through August 10, 2022 but does not require the agency to order cranes from Manitowoc)
TSLA +1.7% (agreed to issue and sell $1.80 bln of senior notes due in 2025)
MYL +1.5% (modestly rebounding following weakness on Friday)
FSLR +1% (receives contract in Australia to supply 241MW Module for for Edify Energy solar projects)
Analyst comments:

FRSX +31.7% (initiated with a Buy at Chardan Capital Markets; tgt $15)
KALA +4.3% (initiated with a Overweight at JP Morgan and added to Focus List)
MASI +1.2% (upgraded to Buy from Neutral at BTIG Research)
TPX +1.1% (upgraded to Overweight from Neutral at Piper Jaffray)
OA +0.9% (upgraded to Buy from Hold at Argus)

Gapping down
In reaction to disappointing earnings/guidance:

SORL -13.9%, JD -5%, TNXP -4.8%, CSIQ -2.5%, GEMP -1%
Select metals/mining stocks trading lower:

GOLD -1.8%, HMY -1.6%, ABX -1.5%, GG -1.2%, AUY -1.1%, NEM -0.9%, IAG -0.9%
Other news:

ZYNE -28.9% (reports top line results from its Phase 2 STOP (Synthetic Transdermal Cannabidiol for Treatment of Knee Pain due to Osteoarthritis) did not meet its primary endpoint)
OPHT -13.3% (announces that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved in its Phase 3 trial investingating Fovista in combination with Eylea)
IPXL -4.9% (modestly declined following last week's 15% advance)
ATRS -3.1% (disclosed $30 mln common stock sales agreement with Cowen and Company)
NFLX -0.9% (Barron's profiles cautious view on Netflix), .
Analyst comments:

CNO -0.8% (downgraded to Underweight at Morgan Stanley)
PSTG -0.5% (downgraded to Hold at Maxim


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/15/17 10:34 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping up
In reaction to strong earnings/guidance:

CMLS +27.9%, PGH +20.4%, BLIN +13%, FORD +12.8%, EXTR +10%, CVV +9.1%, FATE +8.4%, CLRB +8.2%, QIWI +7.8%, WPRT +5.8%, ANY +5.2%, PRKR +3.9%, MBOT +2.8%, XGTI +2.6%, SGLB +1.3%, ECC +1.2%, CLSN +0.7%
Other news:

FRSX +10.8% (continued strength)
P +4.1% (appoints Roger Lynch as CEO and president, and a member of its board of directors, effective September 18, 2017)
SYF +3.6% (new Berkshire Hathaway and Highfields stakes; Senator Investment Group and Omega Advisors also increased positions)
AMD +2.1% (Jericho Capital (Josh Resnick) discloses new position)
STOR +1% (new Berkshire Hathaway position disclosed in today's quarterly filing)
MU +0.9% ( Greenlight Capital (David Einhorn ) discloses new position)
Analyst comments:

IDXG +8.4% (initiated with a Buy at Maxim Group; tgt $5)
GPRO +4.5% (upgraded to Neutral from Sell at Goldman)
SNAP +3.2% (upgraded to Overweight from Neutral at Cantor Fitzgerald)
Wynn+2.5% (upgraded to Buy from Hold at Deutsche Bank)
MDRX +1.3% (upgraded to Overweight at Cantor Fitzgerald)


Gapping down
In reaction to disappointing earnings/guidance:

PLAB -18.2%, (also announces new CFO and Plan to invest a minimum of $160 million over the next five years for its FPD Manufacturing in China), DKS -16.3%, MYO -14.6%, AAP -13.6%, DGLY -11.5%, CGIX -10.4%, NEPT -9.6%, JRJC -7.7%, COH -7.7%, TEAR -6.9%, HOLI -5.4%, PYDS -3%, VJET -2.4%, RETA -1.6%, AST -1.5%, ESLT -0.7%, HD -0.5%
M&A news:

RIG -2% (acquires Songa Offshore SE)
Select AAP peers showing weakness in sympathy:

ORLY -4.2%, AZO -4%, LKQ -0.9%, GPC -0.5%
Select metals/mining stocks trading lower:

AUY -2.3%, AG -2.1%, GOLD -1.9%, SLV -1.5%, GG -1.3%, GDX -1.1%, ABX -1%, GLD -0.8%, NEM -0.6%
Other news:

CRDS -10.6% (after closing near highs - up 35%)
YY -5.2% (commences offering of 5.75 mln ADSs each representing 20 Class A common shares)
ETP -4% (prices offering of 54 mln common units at $18.65 per common unit)
OMER -3.8% (commences public offering of 3 mln shares of its common stock and files mixed securities shelf offering)
G -3.7% (commences 10 mln common stock offering by selling shareholders Bain Capital and GIC Private)
FGEN -2.6% (to offer and sell up to $300 million of its common stock)
NUS -1.8% (continued weakness)
AMH -1.5% (upsizes by 2 mln shares and prices offering of 12 mln shares of Class A stock)
Analyst comments:

UNIT -3.3% (downgraded to Neutral from Buy at BofA/Merrill)
GLW -2.2% (downgraded to Sell from Neutral at Goldman)
DE -1.6% (downgraded to Neutral from Buy at BofA/Merrill)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/16/17 08:16 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping up
In reaction to strong earnings/guidance:

URBN +20.1%, NXTD +5.4%, TGT +5.2%, A +4.5%, JP +1.8%, AGRO +1.5%, XNET +1%
M&A news:

LPLA +8.5% (LPL Financial acquired independent broker-dealer network of Prudential Plc's (PUK) National Planning Holdings; transaction is structured as asset purchase with initial purchase price of $325 mln)
Select URBN peers and related names showing strength:

EXPR +3.4%, BKE +2.6%, TLYS +2.2%, AEO +1.8%, LB +1.3%, ANF +0.9%
Other news:

RADA +20.3% (has received a strategic first order for dozens of Multi-Mission Hemispheric Radars)
IDXG +14.8% (continued strength following yesterday's Buy initiation at Maxim)
PSTI +9.7% (initiates a pilot study of its PLX-R18 cell therapy by the U.S. Department of Defense's Armed Forces Radiobiology Research Institute)
MBRX +4% (acquires WP1122 active drug compound it plans to study for the treatment of brain tumors)
EXEL +3.4% (following Bristol-Myers news - Phase 3 study of Opdivo + Yervoy in with advanced or metastatic Renal Cell Carcinoma did not reach statistical significance), BLCM +2.7% (finalizes Cancer Research Grant Contract with the Cancer Prevention and Research Institute of Texas)
SYF +1.6% (extending yesterday's move higher in after hours following Buffett's Berkshire stake disclosure; also positive Barron's mention)
BHP +1.4% (Elliott confirms it now holds 5% of issued shares of BHP Billiton and releases statement)
FOLD +1.2% (Australian Therapeutic Goods Administration has approved the oral precision medicine Galafold for long-term treatment of adults with a confirmed diagnosis of Fabry disease who have an amenable mutation)
AMD +1.2% (continued strength)
FGEN +1% (prices 8 mln share follow on offering of 8 mln shares of common stock at $40.75 per share)
WMT +1% (in sympathy with TGT)
PRTA +0.9% (will present research on NT-proBNP at the Heart Failure Society of America Annual Scientific Meeting to be held September 16-19)
FATE +0.6% (files for $100 mln mixed securities shelf offering and 1 mln shares of common stock by selling stockholder)
COST +0.6% (in sympathy with TGT)
SUPN +0.5% (confirms it defeated second generic challenger to Oxtellar XR)
Analyst comments:

DXTR +4% (initiated with a Buy at Ladenburg Thalmann; tgt $0.80)
MYL +3.2% (upgraded to Buy from Neutral at Citigroup)
TTMI +2.8% (added to Analyst Focus List at JP Morgan)
BIIB +1.2% (added to Conviction Buy List at Goldman)
BABA +0.8% (initiated with Buy at SunTrust


Gapping down
In reaction to disappointing earnings/guidance:

VIAV -4%, OBSV -2.4%
Other news:

NTEC -4.1% (launches underwritten public offering of its ordinary shares)
BMY -2.4% (Bristol-Myers announces topline results from CheckMate -214, a Phase 3 study of Opdivo + Yervoy in with advanced or metastatic Renal Cell Carcinoma; co-primary endpoint of objective response rate was met for the combo but Progression-Free Survival did not reach statistical significance)
YY -2.2% (prices offering of 5.75 mln ADS's at $70.00 per ADS)
HASI -2.1% (commences $135 mln offering of convertible senior notes due 2022)
NXST -1.5% (attributed to block trade pricing)
NFLX -0.5% (negative response to story AAPL may spend up to $1 bln on original content, according to WSJ)
Analyst comments:

SNAP -0.7% (initiated with Sell at SunTrust)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/17/17 09:09 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping up
In reaction to strong earnings/guidance:

HHS +12.1%, BABA +5.1%, GFI +4.3%, HMY +4.1%, SSI +3.3%, HTHT +3.2%, DPW +1.7%, IMMU +1%
M&A news:

ATU +0.8% (Actuant to sell its Viking SeaTech business to Acteon Group)
Other news:

APOP +4.9% (granted orphan drug designation by the FDA for its compound for the prevention of graft versus host disease)
AERI +4.3% (following VRX news)
AABA +4.2% (in sympathy with BABA)
CVM +3.6% (extending this afternoon's move higher)
RDHL +3.6% (granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release Capsules to gastroenterologists in certain U.S. territories)
TXMD +3.4% (announces publication of manuscript on the Women's Health Initiative Observational Study of vaginal estrogen use in postmenopausal women)
VRX +1.2% (FDA intends to issues a VAI inspection classification for its Bausch + Lomb manufacturing facility in Tampa, Fla. as part of a forthcoming Establishment Inspection Record for the facility )
Analyst comments:

MYOV +4.2% (initiated with Outperform at Evercore ISI)
NTNX +2.4% (initiated with a Buy at Jefferies)
PRTA +2.3% (initiated with Outperform at Evercore ISI)
AVXS +1.8% (initiated with Outperform at Evercore ISI)
SHPG +1.6% (initiated with Outperform at Evercore ISI)
WPRT +1.3% (initiated with a Outperform at Oppenheimer)

Gapping down
In reaction to disappointing earnings/guidance:

LAKE -11.8%, (also launches of secondary offering of common stock), BGG -11.6%, SMRT -11.2%, LB -7.1%, VIPS -5.9%, BKE -4.9%, WMT -2.6%, CSCO -2.5%, NTAP -2.5%, GOGL -2.3%, SNPS -1.4%, SPTN -0.8%, (also announced today that the Company has appointed Mark Shamber as Executive Vice President and Chief Financial Officer, effective September 11, 2017. Shamber previously served as CFO for United Natural Foods, Inc., a specialty and organic food distributor), TOUR -0.6%, CACI -0.5%
Select CSCO peers/related names showing weakness in sympathy:

AMD -1%, ASML -0.8%, NVDA -0.7%, MU -0.6%
Other news:

NLST -22.6% (to offer and sell shares of its common stock in an underwritten registered public offering)
GCAP -4.1% (to offer $80 mln aggregate principal amount of its convertible senior notes due 2022 in a private placement)
FNGN -2.8% (commences 4,109,128 common stock offering by selling stockholders)
ANF -0.9% (following LB results)
Analyst comments:

SAFM -3.5% (downgraded to Equal-Weight from Overweight at Stephens)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/18/17 09:10 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping up
In reaction to strong earnings/guidance:

MNGA +22.4%, SPWH +16.8%, ROST +10.6%, GLOB +8.8%, GPS +5.4%, EL +3.5%, AMAT +3.4%, NWY +1.3%
M&A news:

CPN +9.7% (to be acquired by Energy Capital Partners for $15.25 per share in cash)
Select AMAT peers/related names showing strength:

MU +1.6%, NVDA +0.9%, ASML +0.8%, LRCX +0.6%
Select metals/mining stocks trading higher:

AU +3.2%, GFI +2.9%, AG +2.4%, IAG +2.1%, AUY +1.5%, PAAS +1.4%, ABX +1.1%, GG +1%, SLV +1%, GOLD +0.9%, GDX +0.9%, NEM +0.7%, .
Other news:

CTIC +8.3% (modestly trading higher following multiple day decline)
FLDM +5.6% ( enters into a licensing agreement to offer a next-generation sequencing library prep assay that enables efficient sequencing of the CFTR gene)
CTRL +3.3% (will replace Albany Molecular Research (AMRI) in the S&P SmallCap 600)
MYGN +2.5% (announces positive coverage decision for EndoPredict testing by Palmetto GBA, the Medicare contractor who oversees the MolDx program and Anthem), .
Analyst comments:

HMY +6.2% (upgraded to Hold from Sell at Deutsche Bank)
CBAY +4.8% (initiated with a Buy at SunTrust)
OPK +3.6% (initiated with Overweight at Cantor Fitzgerald)
WAL +1.2% (initiated with a Buy at SunTrust)
BABA +1% (target raised to $185 at RBC Capital Mkts)
PWR +0.7% (upgraded to Buy at Citigroup)

Gapping down
In reaction to disappointing earnings/guidance:

FL -19.6%, ZOES -8.4%, HIBB -7.4%, DE -4%, CRMT -1.4%
Other news:

INFY -7.4% (CEO Dr Vishal Sikka resigns)
ASYS -6.7% (to offer shares of common stock in an underwritten public offering)
FINL -4.9% (in sympathy with FL and HIBB)
JAZZ -3.4% (to offer $500 million aggregate principal amount of exchangeable senior notes due 2024 )
BGFV -2.7% (in sympathy with FL and HIBB)
CNAT -2.5% (files for $100 mln mixed securities shelf offering)
SENS -1.6% (commences common stock offering)
BTU -1.4% (prices secondary offering of 12.8 mln shares of common stock)
Analyst comments:

MATX -4.2% (downgraded to Equal-Weight at Stephens)
APRN -1.7% (downgraded to Hold at Stifel)
BC -1% (downgraded to Neutral at Wedbush

WRAPX This week's biggest % gainers/losers

The following are this week's top 20 percentage gainers and top 20 percentage losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top 20 % gainers
Healthcare: MNKD (1.46 +22.69%), ENDP (8.72 +14.89%), TBPH (27.4 +13.69%), OTIC (18.75 +10.95%), MDXG (16.52 +10.43%), HZNP (13.31 +10.18%)
Materials: HBM (7.9 +11.27%), SHLM (29.55 +10.06%)
Consumer Discretionary: JMEI (3.52 +35.91%)
Information Technology: EXTR (10.68 +23.75%), RENN (8.23 +22.65%), CMCM (12.06 +13.45%), BABA (167.5 +10.42%)
Financials: SUPV (19.96 +12.9%), GGAL (42.44 +11.8%)
Energy: CLMT (6.55 +20.18%), SDLP (3.12 +15.99%), TGS (17.9 +15.11%), TESO (4.4 +12.82%)
Telecommunication Services: TEO (31.11 +10.55%)
This week's top 20 % losers
Healthcare: EDIT (17.83 -18.77%), GEN (1.05 -18.6%), SGRY (9.15 -17.57%), LNTH (15.85 -17.23%)
Industrials: BW (1.95 -32.99%), MATX (22.79 -22.17%), CBI (9.99 -15.34%)
Consumer Discretionary: FL (34.38 -30.26%), DKS (26.99 -20.62%), HIBB (10.9 -20.44%), FINL (11.01 -17.77%), GCO (23.9 -16.72%), TOUR (6.83 -15.57%), ENT (2.51 -15.49%), COH (40.38 -15.08%), BGFV (7.5 -14.29%)
Information Technology: PLAB (7.55 -20.53%)
Energy: DNR (1.16 -17.73%)
Consumer Staples: BETR (6.55 -14.15%)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/21/17 22:38 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564

Gapping down
In reaction to disappointing earnings/guidance
:

  • FRAN -5.9%

M&A news:

  • TOT -0.5% (to acquire Maersk Oil for $7.45 bln in transaction of shares and debt)

Other news:

  • RADA -12.3% (has received and accepted purchase offers from several Israeli institutional investors' to purchase 4,604,500 ordinary shares for $2.15/share), .

Analyst comments:

  • CSIQ -3.8% (downgraded to Underweight from Equal Weight at Barclays)
  • FINL -1.5% (downgraded to Neutral at Monness Crespi & Hardt; downgraded to Sell at UBS)
  • NKE -1.3% (downgraded to Hold from Buy at Jefferies)
  • E -0.7% (downgraded to Underweight from Equal Weight at Barclays)
  • FL -0.6% (downgraded to Neutral from Buy at UBS)
 
   

Gapping up
In reaction to strong earnings/guidance
:

  • WUBA +10.9%, APOP +3.4%

M&A news:

  • FCAU +4.1% (respnds to speculation of interest in Jeep Brand)

Other news:

  • CTRV +11.4% (granted patent that 'significantly extends the claims of the original CRV431 patent family' by the USPTO)
  • HLF +7.4% (commences 'modified Dutch auction' self-tender offer to purchase for cash up to an aggregate of $600 mln of shares of its common stock at a per share price between $60.00-$68.00; discloses recent unsuccessful going-private discussions )
  • TSEM +5.6% (Tower Semi and Tacoma Technology announces that Tower has received a first payment of $18 million net, rendering phase one of the framework agreement with Tacoma binding)
  • SYRS +4.1% (receives orphan drug designation to SY-1425 for the treatment of acute myeloid leukemia from the FDA)
  • CHU +3% (confirms Mixed Ownership Reform Plan; applied for resumption of trading)
  • BZUN +1.5% (trading higher ahead of earnings tonight)
  • SBUX +0.7% (Barron's profiles positive view on Starbucks)

Analyst comments:

  • LULU +2.1% (upgraded to Buy at BofA/Merrill)
  • CENX +2.1% (upgraded to Overweight from Neutral at JP Morgan)
  • AAP +0.5% (upgraded to Equal Weight from Underweight at Barclays)




 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/22/17 09:44 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564

Gapping down
In reaction to disappointing earnings/guidance
:

  • INPX -19.7%, TEDU -13.2%, CMCM -10.1%, MOMO -9.5%, NDSN -9.2%, FN -9%, BZUN -8.4%, SAEX -8.1%, COTY -6.9%, FSAM -5.1%, ZAYO -2.6%, PINC -2.4%, TOL -2%

Other news:

  • TEAR -21.7% (files for offering of $15,000,000 Class A Units consisting of common stock and warrants and Class B Units)
  • OMER -4% (cautious article by Adam Feuerstein (Stat News))

Analyst comments:

  • RDFN -5.8% (initiated with a Neutral at Goldman; tgt $20)
  • HAIN -1.5% (downgraded to Neutral from Positive at Susquehanna)
  • MYL -0.6% (downgraded to Hold from Buy at Argus)

Gapping up
In reaction to strong earnings/guidance
:

  • DSW +15.4%, RT +9.2%, JASO +6.6%, NM +5.7%, BHP +2%, DAKT +1.7%

Other news:

  • EBR +20% (informed by the Minister of Mines and Energy, Fernando Coelho Filho, that the Ministry of Mines and Energy will propose to the Council of the Investment and Partnership Program of the Presidency, the privatization of Eletrobras)
  • HMNY +9.7% (provides further MoviePass update)
  • RDY +3.8% (announces out-licensing of DFD-06)
  • CRSP +3.4% (enters into a two-year research collaboration and license option agreement to develop novel T cell therapies for cancer)
  • M +2.8% (Macy's confirms eBay SVP Hal Lawton named President and announces restructuring actions for merchandising/data analytics)
  • TSEM +2.8% (continued strength)
  • ESV +2.1% (receives new drillship contract award; ENSCO DS-7 contracted to Noble Energy (NBL) in the Mediterranean Seag)
  • AMD +1.2% (modestly rebounding following 4-day declines)
  • SHPG +0.7% (slightly rebounding following yesterday's declines)

Analyst comments:

  • PCRX +1.4% (initiated with Buy at Needham)
  • VMW +1.1% (upgraded to Buy from Hold at Deutsche Bank)
  • BABA +0.6% (upgraded to Overweight from Neutral at Atlantic Equities)

   
   


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/23/17 11:14 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564
Gapping down
In reaction to disappointing earnings/guidance:

CREE -9.7%, LOW -6.6%, ARAY -4.9%, ZTO -3.6%, MTL -3.3%, CRM -2.1%, SYK -1.5%, VNET -0.7%
Other news:

RTNB -40.6% (issued secured convertible promissory notes; intends to use the proceeds to meet its payroll obligations and for other working capital purposes)
RARE -10.9% (announces its Phase 3 study evaluating aceneuramic acid extended release in patients with GNE Myopathy did not achieve its primary endpoint; co will discontinue further development)
CHRS -4.7% (entered into a Registration Rights Agreement in connection with previously announced Purchase Agreement)
GDDY -0.5% (CEO Blake Irving retires but will continue to serve on Board; President and COO Scott Wagner will assume the CEO role effective December 31)
Analyst comments:

TNTR -0.5% (downgraded to Equal-Weight at Morgan Stanley


Gapping up
In reaction to strong earnings/guidance:

EXPR +20.6%, APOG +16.8%, AEO +7.1%, BORN +2.8%
M&A news:

PRTK +30.7% (reports the company may be weighing options after receiving takeover interest)
Other news:

ITCI +33.1% (FDA 'agrees that the Company has presented adequate data to support its position' in nonclinical toxicology studies of lumateperone in an animal species; co intends to submit a NDA by mid-2018)
MBVX +10.8% (thinly traded; announces the closing of $1.3 million registered direct offering and is engaging an advisory bank to explore strategic alternatives)
ACRX +3.4% (amends manufacturing services agreement with Patheon Pharmaceuticals)
SNAP +1.4% (continued strength after eMarketer report/forecast of continued adoption in the US & UK)
GNTX +0.6% (authorizes an additional 15 mln in common share repurchases)
Analyst comments:

DSW +2% (upgraded to Buy from Neutral at B. Riley & Co)
CBAY +1.6% (initiated with a Outperform at Leerink Partners)
ESNT +0.7% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
UNT +0.6% (upgraded to Buy from Hold at KLR Group)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/24/17 15:00 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564

Gapping down
In reaction to disappointing earnings/guidance
:

  • SDRL -20.7%, SJM -4.7%, HPQ -2.4%

Other news:

  • IMUC -16.7% (indicated higher on business update -near-term milestones anticipated in Stem-to-T-Cell program and restructuring underway; will have call today at 5:00 pm ET)
  • GBT -1.7% (files $125 mln mixed securities shelf offering)

Analyst comments:

  • TEVA -2.2% (downgraded to Underperform from Neutral at Credit Suisse)

Gapping up
In reaction to strong earnings/guidance
:

  • SIG +17.7%, LTRX +16.3%, CO +14.8%, GES +14.2%, MIK +9.6%, DLTR +8.7%, TLYS +7.8%, WSM +7.6%, DL +5.1%, PVH +4.7%, CRH +3.8%, PERY +2.2%, LCI +1.8%, EDAP +0.5%

Other news:

  • ENZY +4.1% (Frutarom Industries acquires 9.2% of the ordinary shares of Enzymotec from Paulson and Co for purchase price of $11.50 per share)
  • TTNP +3.3% (receives FDA clearance for the IND application for its ropinirole implant intended for treatment of the signs and symptoms of Parkinson's disease)
  • NPTN +2.5% (after seeing late move higher in optical names)
  • YUME +1.9% (confirms that it is in discussions regarding a potential transaction with RhythmOne)
  • AAOI +1.6% (after seeing late move higher in optical names)
  • LITE +1.5% (after seeing late move higher in optical names)
  • WFM +0.7% (FTC Director confirmed will not to further pursue an investigation of Amazon.com acquisition of Whole Foods Market )
  • BRCD +0.5% (Brocade confirms the Ministry of Commerce of the People's Republic of China issued a written notice that it has granted conditional approval of the proposed acquisition by Broadcom)
  • DKS +0.5% (Director disclosed purchase of 20000 shares valued at approx $524.9K), . 

Analyst comments:

  • CMG +4.4% (upgraded to Equal-Weight from Underweight at Stephens)




 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 8/25/17 09:19 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1564

Gapping down
In reaction to disappointing earnings/guidance
:

  • GME -7.7%, BIG -5.8%, VEEV -5.6%, ULTA -5%, ACET -4.9%, UEPS -2.4%, AVGO -0.9%, VMW -0.7%, .

Analyst comments:

  • TRIP -1.8% (downgraded to Underperform at Jefferies)
  • TWTR -1% ( downgraded to Hold from Buy at Jefferies after the close)
  • HRL -0.6% (downgraded to Neutral from Outperform at Credit Suisse)

Gapping up
In reaction to strong earnings/guidance
:

  • SPLK +10.1%, PSTG +6.7%, ADSK +4.5%, MRVL +2.8%, OSIS +2.2%, BRCD +1.3%, OOMA +0.6%, QADA +0.5%

M&A news:

  • PAH +1.9% (confirms intention to separate into two public companies)
  • EL +1.2% (The Evening Standard discusses market chatter that Unilever (UN/UL) is among interested parties weighing a bid for EL)

Other news:

  • ADMS +54% (granted FDA approval for GOCOVRI)
  • XOMA +28.8% (announces two agreements with Novartis (NVS), will receive $31 mln in upfront payments, including a $5 mln equity investment), KMDA +20.9% (announces KEDRAB has received FDA approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal)
  • TNDM +14% (announces USPTO issuance of patent related to using a software application operating on a remote consumer electronic device)
  • RGSE +12.7% (higher after Chairman resignation and Sonnen collaboration news)
  • CDNA +8.4% (cont strength)
  • URBN +5% (authorized the repurchase of an additional 20 million common shares)
  • Q +3.8% (to join S&P 500)
  • SBAC +3.1% (to join S&P 500)
  • KR +0.7% (after grocers sold off on AMZN/WFM updates)

Analyst comments:

  • ADBE +2% (initiated with Buy at Jefferies)
  • DLTR +1.9% (upgraded to Strong Buy from Mkt Perform at Raymond James)
  • WIX +1.4% (initiated with Buy at Jefferies)
  • SBUX +1.2% (upgraded to Outperform from Neutral at Wedbush)
  • EXPE +0.9% (upgraded to Buy from Hold at Jefferies)



 
 Profile  
Reply to topic 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 544 Posts ]  Go to page Previous  1 ... 32, 33, 34, 35, 36, 37  Next

Home 


Who is online

Users browsing this forum: No registered users and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:

Batch Generator
Hutong9 SizzlingStock GaoFamily  Hearty  TT  股通 财籽 GrusInvest E.T. Yahoo Google msn 大千 未名 外汇牛人邦 CNFinance 华人 investern optionpain YangCai 司空金融网


This site is mainly for stock market discussion, it does not provide any investment advice. It is not suggested to rely on posts here for investment decision.
本网站主要作为股市讨论用途,并不提供任何投资建议。请不要将本站内容作为投资依据,否则风险自负。

钱多多股票论坛 - Trader1688.com© Powered by phpBB © 2002, 2006 phpBB Group